Nature Communications (Jan 2017)

A human immunodeficiency syndrome caused by mutations in CARMIL2

  • T. Schober,
  • T. Magg,
  • M. Laschinger,
  • M. Rohlfs,
  • N. D. Linhares,
  • J. Puchalka,
  • T. Weisser,
  • K. Fehlner,
  • J. Mautner,
  • C. Walz,
  • K. Hussein,
  • G. Jaeger,
  • B. Kammer,
  • I. Schmid,
  • M. Bahia,
  • S. D. Pena,
  • U. Behrends,
  • B. H. Belohradsky,
  • C. Klein,
  • F. Hauck

DOI
https://doi.org/10.1038/ncomms14209
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 13

Abstract

Read online

CARMIL2 (Rltpr) is involved in T-cell function. Here, the authors identify human CARMIL2-deficiency as an autosomal recessive primary immunodeficiency disorder characterized by EBV+smooth muscle tumours, CD28 co-signalling deficiency and impaired cytoskeletal dynamics.